P38 Role of conventional magnetic resonance imaging in the evaluation of patients with neuropsychiatric involvement in systemic lupus erythematosus (SLE)

P38 Role of conventional magnetic resonance imaging in the evaluation of patients with neuropsychiatric involvement in systemic lupus erythematosus (SLE)

Bibliographic Details
Main Authors:	Alessandra Bortoluzzi, Marcello Govoni, Matteo Piga, Antonis Fanouriakis, George Bertsias, Ettore Silvagni, Simone Appenzeller, Antonio Marangoni, Carlo Garaffoni
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
by: Antonis Fanouriakis, et al.
Published: (2019-03-01)

Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study
by: Alessandra Bortoluzzi, et al.
Published: (2025-01-01)

Changing paradigms in the treatment of systemic lupus erythematosus
by: Antonis Fanouriakis, et al.
Published: (2019-12-01)

Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus
by: Alessandra Bortoluzzi, et al.
Published: (2018-03-01)

P85 Predictors of LLDAS and remission in a single-center cohort of patients with lupus nephritis: A retrospective analysis
by: Alessandra Bortoluzzi, et al.
Published: (2024-03-01)

Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions
by: Ettore Silvagni, et al.
Published: (2021-12-01)

Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE)
by: Gareth Garrett, et al.
Published: (2017-01-01)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
by: Valentina Natoli, et al.
Published: (2023-08-01)

Management of Refractory Lupus Nephritis
by: Antonis Fanouriakis, et al.
Published: (2015-07-01)

28 JAK-STAT inhibitors in systemic lupus erythematosus
by: Antonis Fanouriakis
Published: (2023-09-01)

Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review
by: Massimiliano Castellazzi, et al.
Published: (2024-01-01)

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
by: Cristina Cocco, et al.
Published: (2023-06-01)

Blood gene expression of Toll-like receptors in SLE patients with lupus nephritis or neuropsychiatric systemic lupus erythematosus
by: Marketa Dudkova, et al.
Published: (2025-02-01)

Psychiatric disorders in systemic lupus erythematosus (SLE): a serious SLE-related crime
by: Gabriele Nicolosi, et al.
Published: (2013-04-01)

Neuropsychiatric Lupus Erythematosus
by: A. Palma Modoni, et al.
Published: (2011-09-01)

Neuropsychiatric Symptoms in Corticosteroid Induced Systemic Lupus Erythematosus (Sle) Patients: a Case Report
by: Tri Ratnawati
Published: (2024-11-01)

Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms
by: Tom W J Huizinga, et al.
Published: (2019-06-01)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
by: Panagiotis Garantziotis, et al.
Published: (2022-05-01)

Neuropsychiatric systemic lupus erythematosus: where are we now?
by: M. Padovan, et al.
Published: (2011-09-01)

20 Diagnosis and treatment of neuropsychiatric lupus
by: Marcello Govoni
Published: (2020-09-01)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
by: Efrosini Papadaki, et al.
Published: (2021-05-01)

Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre
by: F. De Leonardis, et al.
Published: (2012-12-01)

P70 Exposure to DORIS ≥50% of time and to LLDAS ≥60% of observation time exhibit the best combination of feasibility and protection against adverse outcomes in moderate-to-severe SLE
by: Alessandra Bortoluzzi, et al.
Published: (2024-03-01)

The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results
by: M. Padovan, et al.
Published: (2004-03-01)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
by: Dionysis Nikolopoulos, et al.
Published: (2022-05-01)

Epidemiologi ved systemisk lupus erythematosus (SLE)
by: Inge-Margrethe Gilboe
Published: (2008-01-01)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01)

PO.1.8 Distinct transcriptomic signature of peripheral blood in neuropsychiatric lupus
by: G Bertsias, et al.
Published: (2022-10-01)

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
by: Chessa E, et al.
Published: (2017-09-01)

P19 Regulation of monocyte intracellular metabolism in the inflammatory environment of systemic lupus erythematosus (SLE)
by: Prodromos Sidiropoulos, et al.
Published: (2024-03-01)

21 Neuropsychiatric SLE
by: Ricard Cervera, et al.
Published: (2021-04-01)

Canadian workplace experiences of systemic lupus erythematosus (SLE)
by: Ann E Clarke, et al.
Published: (2021-04-01)

Quality of Life in Patient with Systemic Lupus Erythematosus (SLE)
by: Irma Yanih
Published: (2016-11-01)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
by: Fabio Basta, et al.
Published: (2020-06-01)

Neuropsychiatric involvement in juvenile systemic lupus erythematosus
by: Erkan Demirkaya, et al.
Published: (2008-04-01)

Comprehensive Insights into Neuropsychiatric Systemic Lupus Erythematosus
by: Monika Turek, et al.
Published: (2024-08-01)

Autoimmune pathogenesis of neuropsychiatric systemic lupus erythematosus
by: Chang-hao XIE, et al.
Published: (2014-09-01)

P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series
by: George Bertsias, et al.
Published: (2024-03-01)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
by: Myrto Nikoloudaki, et al.
Published: (2023-01-01)

Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)
by: E. Parriel, et al.
Published: (2025-03-01)